Ou Yang

Dr. Ou Yang

Rutgers University New Brunswick
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2020 in Processes
Verified
Journal Article
Open access
PDF file
YCYingjie Chen
Yingjie Chen
OYOu Yang
Ou Yang
CSChaitanya Sampat
Chaitanya Sampat
PBPooja Bhalode
Pooja Bhalode
RRRohit Ramachandran
Rohit Ramachandran
Marianthi IerapetritouMarianthi Ierapetritou
Marianthi Ierapetritou
The development and application of emerging technologies of Industry 4.0 enable the realization of digital twins (DT), which facilitates the transformation of the manufacturing sector to a more agile and intelligent one. DTs are virtual constructs of physical systems that mirror the behavior and dynamics of such physical systems. A fully developed DT consists of physical components, virtual components, and information communications between the two. Integrated DTs are being applied in various processes and product industries. Although the pharmaceutical industry has evolved recently to adopt Quality-by-Design (QbD) initiatives and is undergoing a paradigm shift of digitalization to embrace Industry 4.0, there has not been a full DT application in pharmaceutical manufacturing. Therefore, there is a critical need to examine the progress of the pharmaceutical industry towards implementing DT solutions. The aim of this narrative literature review is to give an overview of the current status of DT development and its application in pharmaceutical and biopharmaceutical manufacturing. State-of-the-art Process Analytical Technology (PAT) developments, process modeling approaches, and data integration studies are reviewed. Challenges and opportunities for future research in this field are also discussed.

9 February 2021 in Processes
Verified
Journal Article
Open access
PDF file
OYOu Yang
Ou Yang
Marianthi IerapetritouMarianthi Ierapetritou
Marianthi Ierapetritou
Due to high demand, monoclonal antibodies (mAbs) production needs to be efficient, as well as maintaining a high product quality. Quality by design (QbD) via predictive process modeling greatly facilitates process understanding and can be used to adjust process parameters to further improve the unit operations. In this work, mechanistic and dynamic kriging models are developed to capture the protein productivity and glycan fractions under different temperatures and pH levels. The design of experiments is used to generate input and output data for model training. The dynamic kriging model shows good performance in capturing the dynamic profiles of cell cultures and glycosylation using only limited input data. The developed model is further used for feasibility analysis, and successfully identifies the operating design space, maintaining high productivity and guaranteed product quality.


21 June 2024
Verified
Book Chapter
Closed access
PDF file
ANAnastasia Nikolakopoulou
Anastasia Nikolakopoulou
OYOu Yang
Ou Yang
GBGabriele Bano
Gabriele Bano
This chapter presents an approach to utilize real-time statistical process monitoring in fed-batch monoclonal antibody production, showcasing its vital role in identifying operation excursions. Using statistical models, process monitoring can enable proactive interventions for process improvement. Different models are developed depending on the collection frequency of the available data. Process variable measurements are collected daily (offline data) or throughout each day (online data) of the operation and are used to construct different models. PCA or trajectory models are constructed depending on whether the process variables are considered static or dynamic in nature, respectively. Each modeling approach and the corresponding statistical measures used for process monitoring are demonstrated on two data sets, one containing nominal data and one containing excursion data. In the dynamic biopharmaceutical landscape, this chapter serves as a practical guide, offering insights for industry practitioners interested in applying real-time statistical process monitoring for enhancing their monoclonal antibody production processes. However, the techniques used in this chapter are not limited to biopharmaceutical applications but can also extend to other pharmaceutical processes as well. <!----> <!----> <!----> <!---->